Stevanato Group

Stevanato Group is a large, global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug lifecycle at each of the development, clinical and commercial stages.

Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

The group has a combined product and service offering in three core areas:

• Drug containment solutions, such as syringes, vials and cartridges
• Drug delivery systems, including autoinjectors, pen injectors, wearables and inhalers
• Device and component manufacturing, including pharmaceutical products, diagnostic consumables and medical components.

The group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly and packaging equipment. Stevanato Group also provides analytical and testing services to study container closure integrity and integration into drug delivery devices, streamlining the drug development process.

Stevanato Group, which was founded in 1949 as a glassware manufacturer, now employs more than 4,300 people across 16 production and commercial sites, with a presence in nine countries, including in Europe, North America and Asia.

Its stock is publicly traded on the New York Stock Exchange (NYSE:STVN), following an initial public offering in July 2021.

What's this?